Greg Zante's Sale of Performance Stock Units in Viking Therapeutics, Inc.

Greg Zante, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the planned sale of 6,185 common stock units acquired as Performance Stock Units. The securities were acquired on October 27, 2025, and the approximate sale date is set for October 28, 2025. The aggregate market value of the securities to be sold is $216,530.67. The sale will be facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services. There are no recent transactions to report in the past three months.